A malignant melanoma tumor suppressor on human chromosome 11

Cancer Research

Volumn 56, Issue 19, 1996, Pages 4487-4492

  Robertson, Gavin ^a   Coleman, Aaron ^a   Lugo, Tracy G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INHIBITION; CHROMOSOME 11Q; GENE LOCUS; GENE TRANSFER; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOMA CELL; MOLECULAR GENETICS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALS; CHROMOSOME BANDING; CHROMOSOMES, HUMAN, PAIR 11; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; HYBRID CELLS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029760198     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Glass, A G., and Hoover, R. N. The emerging epidemic of melanoma and squamous cell skin cancer J. Am. Med. Assoc., 262: 2097-2100, 1989.
2. Ho, V. C., and Sober, A. J. Therapy for cutaneous melanoma: an update. J Am. Acad. Dermatol, 22: 159-176, 1990.
3. Imber, M. J., and Mihm, M. C., Jr Biological and prognostic significance of vertical growth phase characteristics in malignant melanoma In: M. C. Mihm, Jr., G. F. Murphy, and N. Kaufman (eds.), Pathobiology and Recognition of Malignant Melanoma; Monographs in Pathology, pp. 19-34. Baltimore: Williams & Wilkins, 1988.
4. Cowan, J. M., Halaban, R , and Francke, U. Cytogenetic analysis of melanocytes from premalignant nevi and melanomas J. Natl Cancer Inst , 80 1159-1164, 1988.
5. Hussussian, C J., Struewing, J. P., Goldstein, A. M , Higgins, P A. T., Ally, D S., Sheahan, M. D. Clark, W H. J., Tucker, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15-21, 1994.
6. Fountain, J. W., Bale, S. J., Housman, D. E , and Dracopoli, N. C Genetics of melanoma. Cancer Surv , 9: 645-671, 1990.
7. Thompson, F. H., Emerson, J., Olson, S., Weinstein, R., Leavitt, S. A., Leong, S P. L., Emerson, S , Trent, J. M., Nelson, M. A., Salmon, S. E., and Taetle, R. Cytogenetics in 158 patients with regional or disseminated melanoma: subset analysis of near diploid and simple karyotypes. Cancer Genet Cytogenet., 83: 93-104, 1995
8. Trent, J M., Stanbridge, E J., McBride, H. L , Meese, E U., Casey, G., Araujo, D. E., Witkowski, C M., and Nagle, R. B. Tumorigenicity in human melanoma lines controlled by introduction of human chromosome 6 Science (Washington DC), 247: 568-571, 1990.
9. Cowan, J. M., and Francke, U. Cytogenetic analysis in melanoma and nevi Cancer Treat. Res. 54: 3-16, 1991.
10. Herbst, R. A., Larson, A., Weiss, J., Cavenee, W. K., Hampton, G. M., and Arden, K. C. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma. Cancer Res , 55: 2494-2496, 1995.
11. Tomlinson, I. P., Gammack, A. J , Stickland, J. E., Mann, G. J., MacKie, R. M., Kefford, R. F., and McGee, J. O. Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers. Genes Chromosomes & Cancer, 7: 169-172, 1993
12. Trent, J. M., Meyskens, F. L., Salmon, S E., Ryschon, K., Leong, S. P , Davis, J R., and McGee, D. L Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma. N. Engl. J. Med , 322, 1508-1511, 1990.
13. Johnson, J. P , Demmer-Dieckmann, M., Meo, T., Hadam, M R , and Riethmuller, G. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin. Eur J. Immunol., 11: 825-831, 1981.
14. Lugo, T. G., Handelin, B , Killary, A. M., Housman, D E., and Fournier, R. E. K. Isolation of microcell hybrid clones containing retroviral insertions into specific human chromosomes. Mol. Cell Biol., 7: 2814-2820, 1987.
15. Barch, M J. (ed.) The ACT Cytogenetics Laboratory Manual, 2nd ed , pp. 180-181, 433-434 New York, Raven Press, 1991
16. Trask, B., and Pinkel, D. Fluorescence in situ hybridization with DNA probes In: H. A Crissman and Z. Darzynkiewicz (eds.). Methods in Cell Biology, pp. 383-400, New York: Academic Press, 1990
17. Bell, G I., Karam, J. H., and Rutter, W J. Polymorphic DNA region adjacent to the 5′ end of the human insulin gene Proc. Natl. Acad Sci USA. 78: 5759-5763, 1981.
18. Lugo, T. G., and Witte, O. N. The BCR-ABL oncogene transforms Rat-1 cells and co-operates with v-myc Mol. Cell Biol , 9: 1263-1270, 1989.
19. Miele, M E., Robertson, G . Lee, J-H., Coleman, A , McGary, C T., Fisher, P B., Lugo, T. G., and Welch, D. R Metastasis is suppressed in human melanoma cell line MelJuSo following introduction of human chromosomes 1 or 6 but tumorigenicity and local invasiveness are unaffected Mol. Carcinog., 15: 284-299, 1996.
20. Loh, W E., Jr., Scrable, H. J., Livanos, E., Arboleda, M. J , Cavenee, W K., Oshimura, M., and Weissman, B. E. Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma Proc. Natl Acad. Sci. USA, 89: 1755-1759, 1992
21. Horikawa, I , Okamoto, A , Yokota, J., and Oshimura, M. Genetic heterogeneity of chromosome 11 associated with tumorigenicity in HeLa D98-OR cells Cancer Genet Cytogenet., 85: 97-100, 1995
22. Healy, E., Rehman, I., Angus, B , and Rees, J. L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes & Cancer, 12: 152-156, 1995.
23. Walker, G. J , Palmer, J. M , Walters, M. K., and Hayward, N. K. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosomes & Cancer, 12: 134-141, 1995.
24. Hampton, G M , Mannermaa, A., Winquist, R., Alavaikko, M., Blanco, G., Taskinen, P. J., Kiviniemi, H., Newsham, I , Cavenee, W. K., and Evans, G A. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res , 54: 4586-4589, 1994.
25. Carter, S. L., Negrini, M., Baffa, R., Gillum, D. R., Rosenberg, A L , Schwartz, G. F , and Croce, C. M. Loss of heterozygosity at 11q22-q23 in breast cancer Cancer Res., 54: 6270-6274, 1994.
26. Negrini, M , Rasio, D., Hampton, G. M., Sabbioni, S., Rattan, S , Carter, S L , Rosenberg, A. L., Schwartz, G. F., Shiloh, Y., Cavenee, W. K., and Croce, C. M Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res., 55: 3003-3007, 1995
27. Winqvist, R., Hampton, G. M., Mannermaa, A., Blanco, G , Alavaikko, M., Kiviniemi, H , Taskinen, P. J., Evans, G. A., Wright, F. A., Newsham, I , and Cavenee, W. K Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res., 55: 2660-2664, 1995.
28. Gudmundsson, J , Barkardottir, R. B , Eiriksdottir, G , Baldursson, T., Arason, A , Egilsson, V., and Ingvarsson, S Loss of heterozygosity at chromosome 11 in breast cancer association of prognostic factors with genetic alterations. Br. J. Cancer, 72: 696-701, 1995.
29. Tomlinson, I P , Strickland, J. E., Lee, A. S., Bromley, L , Evans, M. F., Morton, J., and McGee, J. O. Loss of heterozygosity on chromosome 11q in breast cancer. J. Clin Pathol., 48: 424-428, 1995
30. Foulkes, W. D , Campbell, I. G., Stamp, G W., and Trowsdale, J Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer Br. J. Cancer, 67: 268-273, 1993.
31. Davis, M., Hitchcock, A. Foulkes, W. D., and Campbell, I. G. Refinement of two chromosome 11 regions of loss of heterozygosity in ovarian cancer. Cancer Res., 56, 741-744, 1996.
32. Gabra, H , Watson, J. E. V., Taylor, K. J., Mackay, J., Leonard, R. C. F., Steel, C. M., Porteous, D. J., and Smyth, J. F. Definition and refinement of a region of loss of heterozygosity at 11q23 3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res., 56: 950-954, 1996.
33. Rasio, D., Negrini, M., Manenti, G., Dragani, T. A., and Croce, C. M. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res., 55: 3988-3991, 1995.
34. Iizuka, M , Sugiyama, Y , Shiraishi, M , Jones, C., and Sekiya, T. Allelic losses in human chromosome 11 in lung cancers Genes Chromosomes & Cancer, 13: 40-46, 1995
35. Baffa, R., Negrini, M., Mandes, B., Rugge, M., Ranzani, G N., Hirohashi, S., and Croce, C. M Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res., 56: 268-272, 1996.
36. Keldysh, P L , Dragani, T A., Fleischman, E. W , Konstantinova, L. N., Perevoschikov, A. G., Pierotti, M. A. Della Porta, G., and Kopnin, B. P 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes & Cancer, 6 45-50, 1993.
37. Hampton, G. M., Penny, L. A , Baergen, R N., Larson, A., Brewer, C., Liao, S., Busby-Earle, R M , Williams, A. W., Steel, C. M., Bird, C C , Stanbridge, E J., and Evans, G A. Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24 Proc. Natl Acad. Sci. USA, 91: 6953-6957, 1994
38. Srivatsan, E. S., Misra, B. C , Venugopalan, M , and Wilczynski, S. P Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am J Hum. Genet., 49: 868-877, 1991
39. Bethwaite, P. B., Koreth, J., Herrington, C S., and McGee, J O Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma Br J. Cancer, 71, 814-818, 1995.
40. Negrini, M. Sabbioni, S., Possati, L , Rattan, S., Corallini, A., Barbanti-Brodano, G., and Croce, C M Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11 Cancer Res , 54: 1331-1336, 1994
41. Satoh, H., Lamb, P. W , Dong, J. T., Eventi, J., Boreiko, C., Oshimura, M., and Barrett, J C. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer. Mol. Carcinog., 7: 157-164, 1993.
42. Koi, M., Monta, H , Yamada, H., Satoh, H., Barrett, J C., and Oshimura, M. Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol. Carcinog., 2, 12-21, 1989.
43. Misra, B C., and Srivatsan, E. S Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome 11 Am J. Hum. Genet , 45: 565-577, 1989.
44. Larsson, C., Webei, G., Teh, B T , and Lagercrantz. J. Genetics of multiple endocrine neoplasia type 1. Ann N. Y. Acad. Sci., 733: 453-463, 1994.
45. Savitsky, K., Bar-Shira, A. Gilad, S , Rolman, G., Ziv, Y , Vanagaite, L , Tagle, D A., Smith, S , Uziel, T , Sfez, S , Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R , Patanjali, S R , Simmons, A , Clines, G. A , Sartiel, A , Gatti, R A., Chessa, L., Sanal, O., Lavin, M F , Jaspers, N G J., Taylor, A. M. R , Arlett, C F., Miki, T , Weissman, S. M , Lovett, M., Collins, F. S., and Shiloh, Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (Washington DC), 268: 1749-1753, 1995
46. Besnard-Guenn, C., Newsham, I., Winqvist, R., and Cavenee, W. K A common region of loss of heterozygosity in Wilms' tumor and embryonal rhabdomyosarcoma distal to the D11S988 locus on chromosome 11p15.5. Hum Genet, 97: 163-170, 1996.
47. Koi, M , Johnson, L A , Kalikin, L M , Little, P. F., Nakamura, Y , and Feinberg, A P. Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11 Science (Washington DC), 260: 361-364, 1993.
48. Rodeck, U., Bossler, A , Kari, C., Humphreys, C. W., Gjorfi, T , Maurer, J., Thiel, E., and Menssen, H D Expression of the wtl Wilms' tumor gene by normal and malignant human melanocytes Int J Cancer, 59: 78-82, 1994